See more : Tracker Securities on SEBAX Ind (CH0568452707.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai MicroPort MedBot (Group) Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Hempsana Holdings Ltd. (HMPS.CN) Income Statement Analysis – Financial Results
- MEGAIN Holding (Cayman) Co., Ltd. (6939.HK) Income Statement Analysis – Financial Results
- eBullion, Inc. (EBML) Income Statement Analysis – Financial Results
- NeoCore Technology Co., Ltd. (4131.TWO) Income Statement Analysis – Financial Results
- Cascadia Investments, Inc. (CDIV) Income Statement Analysis – Financial Results
Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)
About Shanghai MicroPort MedBot (Group) Co., Ltd.
Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; Honghu, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy. Shanghai Microport Medbot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai Microport Medbot (Group) Co., Ltd. operates as a subsidiary of MicroPort Scientific Corporation.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 104.59M | 21.60M | 2.15M | 0.00 | 0.00 |
Cost of Revenue | 89.90M | 15.04M | 1.23M | 0.00 | 0.00 |
Gross Profit | 14.69M | 6.56M | 919.00K | 0.00 | 0.00 |
Gross Profit Ratio | 14.05% | 30.38% | 42.74% | 0.00% | 0.00% |
Research & Development | 569.18M | 755.80M | 392.65M | 135.38M | 61.88M |
General & Administrative | 126.36M | 170.47M | 150.98M | 11.33M | 2.28M |
Selling & Marketing | 238.43M | 184.04M | 79.19M | 2.69M | 0.00 |
SG&A | 364.79M | 354.51M | 230.16M | 14.02M | 2.28M |
Other Expenses | 55.87M | -4.97M | -11.71M | 13.27M | 6.17M |
Operating Expenses | 989.83M | 1.11B | 611.10M | 162.67M | 70.34M |
Cost & Expenses | 1.08B | 1.12B | 612.33M | 162.67M | 70.34M |
Interest Income | 8.69M | 26.65M | 22.07M | 8.09M | 1.07M |
Interest Expense | 18.41M | 11.13M | 5.29M | 49.13M | 520.00K |
Depreciation & Amortization | 111.76M | 100.71M | 35.37M | 1.66M | 1.11M |
EBITDA | -893.36M | -1.01B | -543.84M | -160.93M | -69.23M |
EBITDA Ratio | -854.14% | -4,663.56% | -27,412.28% | 0.00% | 0.00% |
Operating Income | -975.14M | -1.10B | -610.18M | -158.43M | -69.27M |
Operating Income Ratio | -932.32% | -5,086.28% | -28,380.60% | 0.00% | 0.00% |
Total Other Income/Expenses | -48.39M | -51.02M | -32.81M | -50.86M | -531.00K |
Income Before Tax | -1.02B | -1.15B | -584.51M | -209.29M | -69.80M |
Income Before Tax Ratio | -978.59% | -5,306.13% | -27,186.37% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 20.51M | -41.82M | 51.96M | 520.00K |
Net Income | -1.01B | -1.17B | -542.69M | -261.25M | -70.32M |
Net Income Ratio | -967.74% | -5,401.06% | -25,241.44% | 0.00% | 0.00% |
EPS | -1.06 | -1.22 | -0.59 | -0.27 | -0.07 |
EPS Diluted | -1.06 | -1.22 | -0.59 | -0.27 | -0.07 |
Weighted Avg Shares Out | 958.59M | 958.59M | 919.85M | 953.16M | 953.16M |
Weighted Avg Shares Out (Dil) | 958.59M | 958.59M | 919.85M | 953.16M | 953.16M |
Source: https://incomestatements.info
Category: Stock Reports